2nd Conference
Rapid Microbial NGS and Bioinformatics:
Translation Into Practice

Hamburg/Germany, June 9-11, 2016

This conference is registered as a training event at the Medical Association Hamburg (Ärztekammer Hamburg).
Medical doctors can earn up to 19 training points.

Submit an abstract
Become a sponsor

Important deadlines (EXTENDED!)

Late online registration

May 26, 2016 (registration fees: 300 €)

The consortium of the EU-funded project PathoNGenTrace is delighted to invite you to the 2nd “Rapid Microbial NGS and Bioinformatics: Translation Into Practice” conference which will take place in Hamburg/Germany from June 9 to 11, 2016. The bi-annual meeting will gather experts from all over the world active in applying Next Generation Sequencing (NGS) techniques to discover the epidemiology, anti-microbial resistance, ecology and evolution of microorganisms.

The 2016 conference is targeted at scientists from the academic as well as the public health, food, veterinary, clinical and microbial forensics sectors. In addition, the conference will particularly address the interests of NGS data software developers intending to build a bridge between software developers and end-users. The conference will be open to 140 participants.

Main topics to be covered:
  • User-friendly bioinformatics tools
  • Pathogen tracing by genomics
  • Antimicrobial resistance geno- to phenotype prediction
  • Metagenomics
  • NGS pathogen discovery
  • NGS point of care technology
Program Chairs:

Dag Harmsen (University Münster), Stefan Niemann (Research Center Borstel), Lothar H. Wieler (Robert Koch Institute)

Scientific program advisors:

Thomas Dobner (Heinrich Pette Institute, Hamburg), Rolf Horstmann (Bernhard Nocht Institute for Tropical Medicine, Hamburg), Martin Maiden (University of Oxford, Oxford), Bruno Pot (Applied Maths NV, Gent), Philip Supply (Institute Pasteur, Lille)


Erika-Haus (University Hospital Hamburg) Hamburg, Germany


June 9-11, 2016


Restricted to 140

Registration Fee:

€ 300 (VAT included)



Program Management:

Birte Kretschmer, Ina Filla (Eurice)

Confirmed Speakers:
  • Lothar H. Wieler (Robert Koch Institute, Germany)
  • Marc Struelens (European Centre for Disease Prevention and Control, Sweden)
  • Martin Maiden (University of Oxford, UK)
  • Katia Rouzeau-Szynalski (Nestlé Research Center, Switzerland)
  • Birgitta Duim (Utrecht University, Netherlands)
  • Linda van der Graaf-van Bloois (Utrecht University, Netherlands)
  • Daniel Huson (Tübingen University, Germany)
  • Torsten Semmler (Robert Koch Institute, Germany)
  • Guido Werner (Robert Koch Institute, Germany)
  • Thijs Bosch (National Institute for Public Health and the Environment, Netherlands)
  • Erik Alm (Public Health Agency of Sweden)
  • Andrew McArthur (McMaster University, Canada)
  • Philippe Supply (Centre national de la recherche scientifique, France)
  • Alison J. Cody (University of Oxford, UK)
  • Matthew J. Ellington (Public Health England)
  • Adam Grundhoff (Heinrich Pette Institute, Germany)
  • Robert Schlaberg (University of Utah, USA)
  • Sabin-Christin Kornell (Kiel University, Germany)
  • Alexander Mellmann (University of Muenster, Germany)
  • Mohamend Abdelbary (Lausanne University Hospital, Switzerland)
  • Sofia Hauck (University of Oxford, UK)
  • Aldert Zomer (Utrecht University, Netherlands)
  • Joao Carrico (University of Lisboa, Portugal)
  • Keith Jolley (University of Oxford, UK)
  • Jörg Rothgänger (Ridom GmbH, Germany)
  • Katrien de Bruyn (Applied Math, Belgium)
  • Gary Domselaar (University of Manitoba, Canada)
  • Bernhard Haubold (Max Planck Institute for Evolutionary Biology, Germany)
  • Matthias Merker (Research Center Borstel, Germany)
  • Stephan Günther (Bernhard Nocht Institute for Tropical Medicine, Germany)
  • John W. A. Rossen (University Medical Center Groningen, Netherlands)
  • Viola Schleusener (Research Center Borstel, Germany)

Our Sponsors

  • Advanced Analyitcal
  • Gilson, Inc
  • Illumina
  • Sarstedt
  • Thermo Fisher Scientific
  • European Society of Mycobacteriology

The PathoNGen-Trace project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement No 278864.